AMIKACIN (AMIKACIN SULFATE) — all Canadian products
10 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is AMIKACIN (AMIKACIN SULFATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02173336 | AMIGLYDE-V | ZOETIS CANADA INC | Solution | Intrauterine | AMIKACIN (AMIKACIN SULFATE) 250 MG | Marketed | |
| 02529459 | AMIKACIN SULFATE INJECTION | JAMP PHARMA CORPORATION | Solution | Intramuscular; Intravenous | AMIKACIN (AMIKACIN SULFATE) 250 MG | Marketed | |
| 02486717 | AMIKACIN SULFATE INJECTION | OMEGA LABORATORIES LIMITED | Solution | Intravenous; Intramuscular | AMIKACIN (AMIKACIN SULFATE) 250 MG | Marketed | |
| 02481073 | AMIKACIN SULFATE INJECTION USP | MARCAN PHARMACEUTICALS INC | Solution | Intravenous; Intramuscular | AMIKACIN (AMIKACIN SULFATE) 500 MG | Marketed | |
| 02242971 | AMIKACIN SULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | Liquid | Intramuscular; Intravenous | AMIKACIN (AMIKACIN SULFATE) 250 MG | Marketed | |
| 02539535 | AMIKACIN SULFATE INJECTION | JUNO PHARMACEUTICALS CORP. | Solution | Intramuscular; Intravenous | AMIKACIN (AMIKACIN SULFATE) 250 MG | Cancelled Pre Market | |
| 02525909 | AMIKACIN SULFATE INJECTION | HIKMA CANADA LIMITED | Solution | Intravenous; Intramuscular | AMIKACIN (AMIKACIN SULFATE) 250 MG | Cancelled Post Market | |
| 00397415 | AMIKIN | BRISTOL-MYERS SQUIBB CANADA | Solution | Intravenous; Intramuscular | AMIKACIN (AMIKACIN SULFATE) 250 MG | Cancelled Post Market | |
| 02489147 | ERFA-AMIKACIN | SEARCHLIGHT PHARMA INC | Solution | Intramuscular; Intravenous | AMIKACIN (AMIKACIN SULFATE) 250 MG | Cancelled Post Market | |
| 02506599 | VPI-AMIKACIN | VPI PHARMACEUTICALS INC | Solution | Intramuscular; Intravenous | AMIKACIN (AMIKACIN SULFATE) 500 MG | Dormant |
Browse other molecules: